Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cleator

Showing results (201-210 of 237) with videos related to

Pageof 24
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 6, 2003
An international external quality assessment of nucleic acid amplification of herpes simplex virusLottie Schloss, Anton M van Loon, Paola Cinque, et al.
Journal of Thrombosis and Thrombolysis|October 9, 2015
Evaluation of the F2R IVS-14A/T PAR1 polymorphism with subsequent cardiovascular events and bleeding in patients who have undergone percutaneous coronary interventionEitan A Friedman, Luisa Texeira, Jessica Delaney, et al.
Clinical Breast Cancer|June 14, 2011
Human epidermal growth factor receptor 2-positive breast cancer relapsing post-adjuvant trastuzumab: pattern of recurrence, treatment and outcomeJonathan Krell, Colin R James, Deep Shah, et al.
Annals of the Royal College of Surgeons of England|October 24, 2015
Adequacy of diagnostic tests and surgical management of symptomatic invasive lobular carcinoma of the breastD J Hadjiminas, K E Zacharioudakis, M K Tasoulis, et al.
British Journal of Cancer|November 30, 2006
Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapyJ-Y Pierga, J S Reis-Filho, S J Cleator, et al.
Clinical Breast Cancer|May 17, 2011
Management and outcome of HER2-positive early breast cancer treated with or without trastuzumab in the adjuvant trastuzumab eraCarlo Palmieri, Deep Shah, Jonathan Krell, et al.
Journal of Clinical Microbiology|August 15, 1998
Multicenter evaluation of the Amplicor Enterovirus PCR test with cerebrospinal fluid from patients with aseptic meningitis. The European Union Concerted Action on Viral Meningitis and EncephalitisK E van Vliet, M Glimâker, P Lebon, et al.
Breast Cancer Research and Treatment|March 16, 2012
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumabNancy U Lin, Eric P Winer, Duncan Wheatley, et al.
Clinical Pharmacology and Therapeutics|December 24, 2015
Physician response to implementation of genotype-tailored antiplatelet therapyJ F Peterson, J R Field, K M Unertl, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2004
Synthesis of the thapsigarginsSteven V Ley, Alessandra Antonello, Emily P Balskus, et al.
Pageof 24

Showing results (201-210 of 237) with videos related to

Sort By:
Pageof 24
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 6, 2003
An international external quality assessment of nucleic acid amplification of herpes simplex virusLottie Schloss, Anton M van Loon, Paola Cinque, et al.
Journal of Thrombosis and Thrombolysis|October 9, 2015
Evaluation of the F2R IVS-14A/T PAR1 polymorphism with subsequent cardiovascular events and bleeding in patients who have undergone percutaneous coronary interventionEitan A Friedman, Luisa Texeira, Jessica Delaney, et al.
Clinical Breast Cancer|June 14, 2011
Human epidermal growth factor receptor 2-positive breast cancer relapsing post-adjuvant trastuzumab: pattern of recurrence, treatment and outcomeJonathan Krell, Colin R James, Deep Shah, et al.
Annals of the Royal College of Surgeons of England|October 24, 2015
Adequacy of diagnostic tests and surgical management of symptomatic invasive lobular carcinoma of the breastD J Hadjiminas, K E Zacharioudakis, M K Tasoulis, et al.
British Journal of Cancer|November 30, 2006
Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapyJ-Y Pierga, J S Reis-Filho, S J Cleator, et al.
Clinical Breast Cancer|May 17, 2011
Management and outcome of HER2-positive early breast cancer treated with or without trastuzumab in the adjuvant trastuzumab eraCarlo Palmieri, Deep Shah, Jonathan Krell, et al.
Journal of Clinical Microbiology|August 15, 1998
Multicenter evaluation of the Amplicor Enterovirus PCR test with cerebrospinal fluid from patients with aseptic meningitis. The European Union Concerted Action on Viral Meningitis and EncephalitisK E van Vliet, M Glimâker, P Lebon, et al.
Breast Cancer Research and Treatment|March 16, 2012
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumabNancy U Lin, Eric P Winer, Duncan Wheatley, et al.
Clinical Pharmacology and Therapeutics|December 24, 2015
Physician response to implementation of genotype-tailored antiplatelet therapyJ F Peterson, J R Field, K M Unertl, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2004
Synthesis of the thapsigarginsSteven V Ley, Alessandra Antonello, Emily P Balskus, et al.
Pageof 24